Morning Versus Evening Administration of Intranasal Mometasone Furoate in Seasonal Allergic Rhinitis: A Baseline-Adjusted Comparative Study

Key Points

• To compare the clinical benefits of morning versus evening administration of intranasal mometasone furoate in seasonal allergic rhinitis.
• Comparative study design assessing clinical outcomes based on dosing time.
• Participants received intranasal mometasone furoate either in the morning or evening.
• Baseline-adjusted analysis was utilized to evaluate the effectiveness of each dosing time.
• Both morning and evening administrations yielded comparable clinical benefits in patients with moderate-to-severe SAR.
• No significant differences were found in efficacy between the two dosing times, suggesting patient preference can guide treatment.
• Dosing time of intranasal corticosteroids may not impact long-term clinical outcomes.